StockNews.com assumed coverage on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Free Report) in a report published on Sunday. The firm issued a sell rating on the biopharmaceutical company’s stock.

Pfizer Inc. (NYSE:PFE – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the sixteen ratings ...